Summary & Overview
Other Musculoskeletal System and Connective Tissue O.R. Procedures without CC/MCC: Inpatient Reimbursement Overview
DRG 517 covers other musculoskeletal system and connective tissue operating room procedures without Major Complication or Comorbidity or Complication or Comorbidity, defining a lower-severity surgical inpatient category. This grouping matters for inpatient reimbursement because it establishes the prospectively determined payment rate tied to the principal procedure and documented comorbidity level.
DRG 517 Overview
DRG 517 groups inpatient stays for other musculoskeletal system and connective tissue operating room procedures without Major Complication or Comorbidity or Complication or Comorbidity. It captures a range of surgical interventions on bones, joints, soft tissues, and connective structures that are not classified elsewhere and that occur without significant comorbid conditions. This Diagnosis-Related Group matters for Medicare payment because it defines the bundled prospective reimbursement for the hospital stay based on procedure and comorbidity level. Accurate clinical and coding documentation determines that cases are assigned to this lower-severity payment category rather than higher-paying groups.
Clinical Trials
- Studies evaluating perioperative pain management and opioid-sparing multimodal analgesia for patients undergoing non-spine musculoskeletal and connective tissue operations (e.g., joint debridement, tendon repair, soft-tissue tumor excision) in the acute surgical setting. These trials focus on immediate postoperative analgesic regimens, regional anesthesia techniques, and metrics such as opioid consumption, pain scores, length of stay, and early complications in adult and older adult surgical patients. This research is relevant to providers and payers because optimized analgesia can reduce inpatient length of stay, opioid-related adverse events, and resource utilization tied to this DRG.
- Comparative effectiveness studies of surgical techniques and perioperative care pathways for elective and urgent non-spine musculoskeletal O.R. procedures without major comorbidities, comparing outcomes such as operative time, complication rates, readmissions, and functional recovery. Typical patient populations include otherwise generally healthy adults undergoing procedures like arthroscopic tendon repairs, soft-tissue mass excisions, or open reductions without CC/MCC; investigators assess whether less invasive approaches or standardized perioperative protocols produce better value. Findings inform clinicians and payers about which procedures and care bundles yield superior short-term outcomes and lower total episode costs within the DRG.
- Post-discharge outcomes and rehabilitation trials assessing recovery trajectories, outpatient physical therapy intensity, and return-to-function for patients discharged after non-complex musculoskeletal operations; studies track patient-reported outcomes, unplanned emergency visits, and delayed surgical complications over 30–90 days. These studies often include older adults and working-age patients whose postoperative recovery influences readmission risk and downstream utilization. Results matter to providers and payers because improved outpatient rehabilitation strategies and early identification of complications can reduce readmissions and overall episode-of-care expenditures associated with this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.